# EDGAR Filing Document

**Accession Number:** 0001827401
**File Stem:** 0000000000-25-009199
**Filing Date:** 2025-8
**Character Count:** 2140
**Document Hash:** 57028df3cf7daed34dac09f443b801ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-009199.hdr.sgml**: 20250930

**ACCESSION NUMBER**: 0000000000-25-009199

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250827

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BRIGHT MINDS BIOSCIENCES INC.
- **CENTRAL INDEX KEY:** 0001827401
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-289851

**BUSINESS ADDRESS:**
- **STREET 1:** 19 VESTRY STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10013
- **BUSINESS PHONE:** 6474072515

**MAIL ADDRESS:**
- **STREET 1:** 19 VESTRY STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10013
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001062993-25-014903

## Text-Extract

```

                                                           August 27, 2025

Ian McDonald
Chief Executive Officer
Bright Minds Biosciences Inc.
400 N Aberdeen St., Suite 900
Chicago, IL 60642

       Re: Bright Minds Biosciences Inc.
           Registration Statement on Form F-3
           Filed August 26, 2025
           File No. 333-289581
Dear Ian McDonald:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Jason Drory at 202-551-8342 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:   Michael Shannon

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._